Company / Operating Margin
Haemonetics Operating Margin History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
16.3%
FY2024
5-year range
8.1% / 16.3%
FY2020-FY2024
Trend
+29.4%
vs FY2023
Sector context
#30 of 143
Health Care
What the data says
Haemonetics's operating margin of 16.3% is higher than 79% of companies in the Health Care sector (FY2024). Operating Margin has fluctuated over the past 6 years, ranging from -2.2% in FY2016 to 24.9% in FY2017.
Based on SEC 10-K filings.
16.3% in FY2024 with a 3-year CAGR of +8.2%. Top quartile in the Health Care sector.
Improved from 13.4% to 16.3% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +8.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 21% in Health CareTop 21% of 143This company 16.3% Sector average -295.7%
▼
+105.5% above sector average
Key checks
Key Insights
- In FY2024, operating margin increased 29.4% year-over-year.
- Currently 312.0pp above the Health Care sector average.
- Peak operating margin was recorded in FY2017.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 16.3% | +29.4% |
| FY2023 | 12.6% | -5.7% |
| FY2022 | 13.4% | +64.2% |
| FY2021 | 8.1% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | 24.9% | +1237.9% |
| FY2016 | -2.2% | +54.7% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026